Bristol Myers Squibb Co (BMY)

Mar 31, 2025

Bristol-Myers Squibb Company (BMY): Among the Best High Yield Stocks to Buy in April for Dividend Capture - Insider Monkey

Mar 31, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 31, 2025

BMO maintains Bristol-Myers $61 target, Market Perform rating By Investing.com - Investing.com Australia

Mar 31, 2025

Mar 31, 2025

BMS-986458, a CRBN-mediated LDD targeting BCL6 for B-cell NHL treatment - BioWorld MedTech

Mar 31, 2025

Mar 31, 2025

BMO maintains Bristol-Myers $61 target, Market Perform rating - Investing.com India

Mar 31, 2025

Mar 31, 2025

Major Breakthrough: New Cancer Drug Delivery Method Gets EU Panel Support - Stock Titan

Mar 31, 2025

Mar 31, 2025

Bcwm LLC Invests $6.24 Million in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Mar 31, 2025

Mar 30, 2025

Intrust Bank NA Buys 8,894 Shares of Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Jim Cramer on Bristol-Myers Squibb. Co (NYSE:BMY): They Should Have Known Better - Insider Monkey

Mar 29, 2025

Mar 29, 2025

Bristol Myers Squibb gets Positive EMA Committee opinion for subcutaneous formulation of Opdivo across... - Medical Dialogues

Mar 29, 2025

Mar 29, 2025

Why Bristol-Myers Squibb Co. (BMY) Went Up On Friday? - MSN

Mar 29, 2025

Mar 28, 2025

BMS secures pair of EU recommendations for Opdivo, including injectable form - FirstWord Pharma

Mar 28, 2025

Mar 28, 2025

Bristol-Myers Squibb (NYSE:BMY) Sees Rising Interest in Sotyktu Despite 3% Share Price Dip - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

Bristol Myers Squibb (BMY) Receives EMA Panel Approval Recommendation for Opdivo - GuruFocus

Mar 28, 2025

Mar 28, 2025

Bristol Myers Squibb gets positive CHMP opinion for neoadjuvant Opdivo and chemotherapy - Seeking Alpha

Mar 28, 2025

Mar 28, 2025

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications - BioSpace

Mar 28, 2025

Mar 28, 2025

European committee backs subcutaneous formulation of Bristol Myers’ Opdivo By Investing.com - Investing.com Australia

Mar 28, 2025

Mar 28, 2025

European committee backs subcutaneous formulation of Bristol Myers’ Opdivo - Investing.com

Mar 28, 2025

Mar 28, 2025

Worldwide locations - Bristol Myers Squibb (BMS)

Mar 28, 2025

Mar 27, 2025

Outgoing Bristol-Myers GC Saw Comp Rise To $7M - Law360

Mar 27, 2025

Mar 27, 2025

UBS maintains neutral Bristol-Myers stock with $60 target - Investing.com

Mar 27, 2025

Mar 27, 2025

UBS maintains neutral Bristol-Myers stock with $60 target By Investing.com - Investing.com UK

Mar 27, 2025

Mar 27, 2025

The Escalator: Bristol Myers Squibb, Editas Medicine, Takeda and more - Medical Marketing and Media

Mar 27, 2025

Mar 27, 2025

Why Pfizer Is My Largest Healthcare Position - The Motley Fool

Mar 27, 2025

Mar 26, 2025

Bristol-Myers Squibb Says Board Chair & CEO Christopher S. Boerner's 2024 Total Compensation Was $18.8 MillionSEC Filing - Marketscreener.com

Mar 26, 2025

Mar 26, 2025

SEC Spurns Bristol Myers Bid to Stop Voting on Anti-DEI Plan - Bloomberg Law News

Mar 26, 2025

Mar 26, 2025

Four New Studies Demonstrate that Viz.ai Finds New Patients with Hypertrophic Cardiomyopathy Earlier When Embedded into the Clinical Workflow - Quantisnow

Mar 26, 2025

Mar 26, 2025

Predict First: BMS Executives Discuss Company’s AI Approach - Genetic Engineering and Biotechnology News

Mar 26, 2025

Mar 26, 2025

Global Inclusion & Diversity - Bristol Myers Squibb (BMS)

Mar 26, 2025

Mar 25, 2025

Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MSN

Mar 25, 2025

Mar 25, 2025

Bristol-Myers Squibb's Rally Is Well Deserved, Albeit Warranting A Downgrade To Hold (NYSE:BMY) - Seeking Alpha

Mar 25, 2025

Mar 25, 2025

Bristol-Myers Squibb expands immuno-oncology pipeline with Flexus Biosciences, Rigel Pharmaceuticals deals - FirstWord Pharma

Mar 25, 2025

Mar 25, 2025

Become a business supplier - Bristol Myers Squibb (BMS)

Mar 25, 2025

Mar 24, 2025

Bristol-Myers Squibb’s SWOT analysis: stock faces legacy challenges amid growth potential - Investing.com

Mar 24, 2025

Mar 24, 2025

Is Bristol-Myers Squibb (BMY) The Best Healthcare Dividend Stock to Invest in? - Insider Monkey

Mar 24, 2025

Mar 24, 2025

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga

Mar 24, 2025

Mar 22, 2025

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires? - Insider Monkey

Mar 22, 2025

Mar 21, 2025

Bristol-Myers Squibb Company (BMY): Among Incredibly Cheap Dividend Stock to Buy Now - Insider Monkey

Mar 21, 2025

Mar 21, 2025

Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (NYSE:MRK) - Seeking Alpha

Mar 21, 2025

Mar 20, 2025

Is Bristol-Myers Squibb Company (BMY) The Best Undervalued Stock to Buy According to Billionaires? - Insider Monkey

Mar 20, 2025

Mar 20, 2025

Bristol Myers Squibb Names GM for Saudi Arabia and Gulf Countries - Contract Pharma

Mar 20, 2025

Mar 20, 2025

Bristol Myers Squibb Appoints Osama Braiwish as General Manager for Saudi Arabia & Gulf Countries - The Malaysian Reserve

Mar 20, 2025

Mar 19, 2025

Bristol Myers Squibb (BMY) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance

Mar 19, 2025

Mar 19, 2025

Is Bristol-Myers Squibb (BMY) the Most Undervalued Biotech Stock to Invest In? - Insider Monkey

Mar 19, 2025

Mar 18, 2025

Bristol-Myers Squibb: Why I'm Still Bullish (NYSE:BMY) - Seeking Alpha

Mar 18, 2025

Mar 17, 2025

7 Most Undervalued Biotech Stocks To Invest In - Insider Monkey

Mar 17, 2025

Mar 17, 2025

Bristol-Myers Squibb Company (BMY): A Bull Case Theory - Yahoo

Mar 17, 2025

Mar 17, 2025

EC approves Bristol Myers Squibb’s follicular lymphoma CAR T therapy - Yahoo Finance

Mar 17, 2025